Deliang Cao

China University of Mining and Technology — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

41h-index5.3kcitations129works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Aldose Reductase and Taurine(52), Heme Oxygenase-1 and Carbon Monoxide(19), Prenatal Substance Exposure Effects(18), Cancer, Hypoxia, and Metabolism(16), HER2/EGFR in Cancer Research(13)

Publications129 total

AKR1B1 bridges metabolic pathways and disease progression
Cellular Signalling·2025Open Access
Auditory perception-integrated depthwise separable convolution-transformer hybrid network for coal-gangue ratio recognition
Engineering Research Express·2025
A rebuttal to: A letter to editor entitled: “A panel (CA19-9, CEA and PIVKA-II) of serum markers for pancreatic cancer diagnosis”
Clinical Biochemistry·2025
Corrigendum to “CA19-9, CEA and PIVKA-II as a novel panel of serum markers for diagnosis of pancreatic cancer” [Clin. Biochem. 137 (2025) 110902]
Clinical Biochemistry·2025
Data from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025· 1 citedOpen Access
Figure S7 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Supplementary Table 2 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Figure S8 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Figure S4 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Supplementary Table 1 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Figure S6 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Figure S1 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Figure S5 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Supplementary Data from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Figure S2 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Figure S3 from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
2025Open Access
Trigonelline Attenuated Sepsis-Induced Acute Kidney Injury by Activating NAD+/SIRT1 Pathway
Physiological Research·2025· 1 citedOpen Access
Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2
Molecular Cancer Therapeutics·2025· 1 citedOpen Access
A Large‐Scale Retrospective Study of Serum Des‐Gamma‐Carboxy Prothrombin as a Diagnostic Marker of <scp>HCC</scp>: Effect of Liver Function on Specificity
Journal of Clinical Laboratory Analysis·2025Open Access
CA19-9, CEA and PIVKA-Ⅱ as a novel panel of serum markers for diagnosis of pancreatic cancer
Clinical Biochemistry·2025· 5 cited
page 1 of 7Next →

Frequent Co-authors

Duan‐Fang Liao(11), Qianjin Liao(10), Chenfei Huang(9), Jun Ma(8), Dixian Luo(8), Longzheng Xia(7), Min Su(7), Ruilan Yan(7), Yiwen Bu(7), Jianghua Liu(7), Xuyu Zu(7), Shiming Tan(6), Linda Oyang(6), Yu Cao(6), Zhe Cao(6), Yingchun He(6), Yujuan Zhou(5), Yi Shen(5), Chuan Cai(5), Dan Huang(5)